Nektar Therapeutics
NKTR
#5680
Rank
HK$9.06 B
Marketcap
HK$445.60
Share price
0.67%
Change (1 day)
278.07%
Change (1 year)

Earnings for Nektar Therapeutics (NKTR)

Earnings in 2025 (TTM): -HK$0.89 Billion

According to Nektar Therapeutics 's latest financial reports the company's current earnings are HK$62.6 Million. In 2024 the company made an earning of -HK$0.93 Billion, an increase over its 2023 earnings that were of -HK$2.15 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Nektar Therapeutics from 1994 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -HK$0.89 Billion-4.22%
2024 -HK$0.93 Billion-56.85%
2023 -HK$2.15 Billion-24.31%
2022 -HK$2.84 Billion-30.25%
2021 -HK$4.08 Billion17.87%
2020 -HK$3.46 Billion0.88%
2019 -HK$3.43 Billion-164.46%
2018 HK$5.31 B-810.61%
2017 -HK$0.75 Billion-37.06%
2016 -HK$1.19 Billion89.22%
2015 -HK$0.63 Billion48.22%
2014 -HK$0.43 Billion-65.93%
2013 -HK$1.25 Billion-6.81%
2012 -HK$1.34 Billion28.95%
2011 -HK$1.04 Billion258.8%
2010 -HK$0.29 Billion-63.94%
2009 -HK$0.8 Billion-392.45%
2008 HK$0.27 B-211.74%
2007 -HK$0.25 Billion-79.57%
2006 -HK$1.2 Billion-16.9%
2005 -HK$1.45 Billion81.53%
2004 -HK$0.8 Billion54.19%
2003 -HK$0.52 Billion-33.87%
2002 -HK$0.78 Billion-9.6%
2001 -HK$0.87 Billion73.39%
2000 -HK$0.5 Billion108.9%
1999 -HK$0.24 Billion39.48%
1998 -HK$0.18 Billion60.02%
1997 -HK$0.11 Billion18.05%
1996 -HK$90.25 Million31.82%
1995 -HK$68.46 Million57.14%
1994 -HK$43.57 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
HK$64.13 B-7,345.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$92.20 B-10,516.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$179.62 B-20,393.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Richardson Electronics
RELL
HK$1.17 M-100.13%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$101.83 B-11,604.35%๐Ÿ‡ฌ๐Ÿ‡ง UK
Baxter
BAX
-HK$2.11 Billion 137.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
HK$3.15 B-456.48%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Johnson & Johnson
JNJ
HK$252.02 B-28,571.74%๐Ÿ‡บ๐Ÿ‡ธ USA